Literature DB >> 20593266

Regulators of TLR4 signaling by endotoxins.

Anne F McGettrick1, Luke A J O'Neill.   

Abstract

The stimulation of TLR4 by LPS activates two distinct signaling pathways leading to the expression of diverse inflammatory genes. Intensive studies over the past decade have revealed the components involved in these signaling pathways, however, more recently the focus has shifted somewhat towards the components that regulate these pathways. Several regulatory mechanisms, including localisation of components, splice variants and inhibitory molecules will be discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20593266     DOI: 10.1007/978-90-481-9078-2_7

Source DB:  PubMed          Journal:  Subcell Biochem        ISSN: 0306-0225


  10 in total

1.  Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Authors:  Keiko Hirose; Jared J Hartsock; Shane Johnson; Peter Santi; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2014-06-21

2.  Baicalin Inhibits Lipopolysaccharide-Induced Inflammation Through Signaling NF-κB Pathway in HBE16 Airway Epithelial Cells.

Authors:  Shou-jin Dong; Yun-qing Zhong; Wen-ting Lu; Guan-hong Li; Hong-li Jiang; Bing Mao
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

3.  TLR4 protein contributes to cigarette smoke-induced matrix metalloproteinase-1 (MMP-1) expression in chronic obstructive pulmonary disease.

Authors:  Patrick Geraghty; Abdoulaye J Dabo; Jeanine D'Armiento
Journal:  J Biol Chem       Date:  2011-07-05       Impact factor: 5.157

4.  Neuroinflammation triggered by β-glucan/dectin-1 signaling enables CNS axon regeneration.

Authors:  Katherine T Baldwin; Kevin S Carbajal; Benjamin M Segal; Roman J Giger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

Review 5.  T cell vaccinology: exploring the known unknowns.

Authors:  Matt A Burchill; Beth A Tamburini; Nathan D Pennock; Jason T White; Jonathan S Kurche; Ross M Kedl
Journal:  Vaccine       Date:  2012-11-06       Impact factor: 3.641

6.  Human β-defensin 3 affects the activity of pro-inflammatory pathways associated with MyD88 and TRIF.

Authors:  Fiona Semple; Heather MacPherson; Sheila Webb; Sarah L Cox; Lucy J Mallin; Christine Tyrrell; Graeme R Grimes; Colin A Semple; Matthew A Nix; Glenn L Millhauser; Julia R Dorin
Journal:  Eur J Immunol       Date:  2011-09-06       Impact factor: 5.532

Review 7.  LPS inmobilization on porous and non-porous supports as an approach for the isolation of anti-LPS host-defense peptides.

Authors:  Carlos López-Abarrategui; Alberto Del Monte-Martínez; Osvaldo Reyes-Acosta; Octavio L Franco; Anselmo J Otero-González
Journal:  Front Microbiol       Date:  2013-12-17       Impact factor: 5.640

8.  Dysbiosis of Gram-negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease.

Authors:  Maria V Salguero; Mohammed A I Al-Obaide; Ruchi Singh; Timo Siepmann; Tetyana L Vasylyeva
Journal:  Exp Ther Med       Date:  2019-08-26       Impact factor: 2.447

Review 9.  Transcriptional Activation of Inflammatory Genes: Mechanistic Insight into Selectivity and Diversity.

Authors:  Afsar U Ahmed; Bryan R G Williams; Gregory E Hannigan
Journal:  Biomolecules       Date:  2015-11-11

Review 10.  Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review.

Authors:  Naif A Al-Gabri; Sultan A M Saghir; Sallah A Al-Hashedi; Ali H El-Far; Asmaa F Khafaga; Ayman A Swelum; Abdullah S Al-Wajeeh; Shaker A Mousa; Mohamed E Abd El-Hack; Mohammed A E Naiel; Khaled A El-Tarabily
Journal:  Int J Nanomedicine       Date:  2021-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.